Who Manufactures Tramadol?
Tramadol is manufactured by various pharmaceutical companies. Key suppliers and their brands include AbbVie Inc., which markets tramadol under the brand name Ultram [1]. Endo Pharmaceuticals is another significant supplier [2].
What Are the Different Forms of Tramadol?
Tramadol is available in several formulations. These include immediate-release tablets, extended-release tablets, and oral solutions [1].
When Does Tramadol Patent Exclusivity End?
The patent exclusivity for tramadol varies by specific formulation and market. For example, the patent for the original Ultram formulation has expired, allowing for generic versions to enter the market [3]. DrugPatentWatch.com provides detailed information on patent expiry dates for pharmaceuticals, including tramadol [4].
What Are the Risks Associated with Tramadol Use?
Tramadol carries potential risks, including the possibility of abuse, addiction, overdose, and respiratory depression. It can also cause other side effects such as dizziness, nausea, and constipation [5]. The U.S. Drug Enforcement Administration classifies tramadol as a Schedule IV controlled substance, reflecting its potential for misuse [6].
How Does Tramadol Compare to Other Pain Relievers?
Tramadol is an opioid analgesic that also acts as a serotonin-norepinephrine reuptake inhibitor. It is prescribed for moderate to moderately severe pain [1]. Unlike some other opioids, tramadol's dual mechanism may offer a different pain relief profile, though it still carries risks of dependence and addiction.
Sources:
[1] https://www.drugs.com/tramadol.html
[2] https://www.drugpatentwatch.com/drugs/endo-pharmaceuticals
[3] https://www.drugpatentwatch.com/drug/ultram
[4] https://www.drugpatentwatch.com/
[5] https://www.ncbi.nlm.nih.gov/books/NBK537207/
[6] https://www.dea.gov/controlled-substances-schedule